Subsequent Event - Narrative (Details) - Subsequent Event - Agreement and Plan of Merger with Curium Pharma |
Aug. 03, 2026
$ / shares
|
|---|---|
| Subsequent Event [Line Items] | |
| Date of Merger Agreement | Aug. 03, 2026 |
| Share price (in dollars per share) | $ 102.5 |
| Contingent value right, per share value | $ 12 |
| X | ||||||||||
- Definition Per share price of Contingent Value Right. No definition available.
|
| X | ||||||||||
- Definition Date when acquisition agreement is executed in business combination, in YYYY-MM-DD format. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Per share price of saleable stock paid or offered to be paid by acquirer in business combination. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|